WO2001023409A8 - 38 human secreted proteins - Google Patents

38 human secreted proteins

Info

Publication number
WO2001023409A8
WO2001023409A8 PCT/US2000/026371 US0026371W WO0123409A8 WO 2001023409 A8 WO2001023409 A8 WO 2001023409A8 US 0026371 W US0026371 W US 0026371W WO 0123409 A8 WO0123409 A8 WO 0123409A8
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
relates
proteins
novel human
Prior art date
Application number
PCT/US2000/026371
Other languages
French (fr)
Other versions
WO2001023409A2 (en
Inventor
Craig A Rosen
Steven M Ruben
George A Komatsoulis
Original Assignee
Human Genome Sciences Inc
Craig A Rosen
Steven M Ruben
George A Komatsoulis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002384584A priority Critical patent/CA2384584A1/en
Priority to EP00968411A priority patent/EP1248516A4/en
Priority to JP2001526559A priority patent/JP2003527829A/en
Priority to AU78330/00A priority patent/AU7833000A/en
Application filed by Human Genome Sciences Inc, Craig A Rosen, Steven M Ruben, George A Komatsoulis filed Critical Human Genome Sciences Inc
Publication of WO2001023409A2 publication Critical patent/WO2001023409A2/en
Publication of WO2001023409A8 publication Critical patent/WO2001023409A8/en
Priority to US10/670,186 priority patent/US20070031842A1/en
Priority to US10/670,185 priority patent/US20070015162A1/en
Priority to US10/868,184 priority patent/US20070048818A1/en
Priority to US10/994,608 priority patent/US20070048297A1/en
Priority to US11/781,665 priority patent/US20070298491A1/en
Priority to US12/753,401 priority patent/US8410248B2/en
Priority to US13/848,789 priority patent/US20130203164A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention se rapporte à de nouvelles protéines sécrétées humaines et à des acides nucléiques isolés contenant les régions codantes des gènes codant ces protéines. Cette invention concerne également des vecteurs, des cellules hôtes et des anticorps et des procédés de recombinaison visant à produire des protéines sécrétées humaines. Cette invention concerne en outre des procédés diagnostiques et thérapeutiques servant à diagnostiquer et à traiter des maladies, des troubles et/ou des états associés à ces nouvelles protéines sécrétées humaines.This invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding these proteins. The invention also relates to vectors, host cells and antibodies and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods for diagnosing and treating diseases, disorders and / or conditions associated with these novel human secreted proteins.

PCT/US2000/026371 1999-03-12 2000-09-26 38 human secreted proteins WO2001023409A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA002384584A CA2384584A1 (en) 1999-09-27 2000-09-26 38 human secreted proteins
EP00968411A EP1248516A4 (en) 1999-09-27 2000-09-26 38 human secreted proteins
JP2001526559A JP2003527829A (en) 1999-09-27 2000-09-26 38 human secreted proteins
AU78330/00A AU7833000A (en) 1999-09-27 2000-09-26 38 human secreted proteins
US10/670,185 US20070015162A1 (en) 1999-03-12 2003-09-25 99 human secreted proteins
US10/670,186 US20070031842A1 (en) 1999-03-12 2003-09-25 379 human secreted proteins
US10/868,184 US20070048818A1 (en) 1999-03-12 2004-06-16 Human secreted proteins
US10/994,608 US20070048297A1 (en) 1999-03-12 2004-11-23 Human secreted proteins
US11/781,665 US20070298491A1 (en) 1999-03-12 2007-07-23 Human Secreted Proteins
US12/753,401 US8410248B2 (en) 1999-03-12 2010-04-02 HWBAO62 polypeptides
US13/848,789 US20130203164A1 (en) 1999-03-12 2013-03-22 Human Secreted Proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15580499P 1999-09-27 1999-09-27
US60/155,804 1999-09-27

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/026376 Continuation-In-Part WO2001023402A1 (en) 1999-03-12 2000-09-26 43 human secreted proteins
PCT/US2000/026324 Continuation-In-Part WO2001023598A1 (en) 1999-03-12 2000-09-26 41 human secreted proteins

Related Child Applications (4)

Application Number Title Priority Date Filing Date
PCT/US2000/026376 Continuation-In-Part WO2001023402A1 (en) 1999-03-12 2000-09-26 43 human secreted proteins
PCT/US2000/026324 Continuation-In-Part WO2001023598A1 (en) 1999-03-12 2000-09-26 41 human secreted proteins
US95008201A Continuation-In-Part 1999-03-12 2001-09-12
US95008301A Continuation-In-Part 1999-03-12 2001-09-12

Publications (2)

Publication Number Publication Date
WO2001023409A2 WO2001023409A2 (en) 2001-04-05
WO2001023409A8 true WO2001023409A8 (en) 2002-01-24

Family

ID=22556863

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/026371 WO2001023409A2 (en) 1999-03-12 2000-09-26 38 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1248516A4 (en)
JP (1) JP2003527829A (en)
AU (1) AU7833000A (en)
CA (1) CA2384584A1 (en)
WO (1) WO2001023409A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911335B2 (en) 2001-03-16 2005-06-28 Millennium Pharmaceuticals, Inc. 57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor
FR2826373A1 (en) * 2001-06-20 2002-12-27 Molecular Engines Laboratoires SEQUENCES INVOLVED IN THE PHENOMENA OF TUMOR DEPRESSION, TUMOR REVERSION APOPTOSIS AND / OR RESISTANCE TO VIRUSES AND THEIR USE AS MEDICAMENTS

Also Published As

Publication number Publication date
AU7833000A (en) 2001-04-30
CA2384584A1 (en) 2001-04-05
EP1248516A2 (en) 2002-10-16
JP2003527829A (en) 2003-09-24
WO2001023409A2 (en) 2001-04-05
EP1248516A4 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
EP1053245A4 (en) 45 human secreted proteins
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998040483A3 (en) 28 human secreted proteins
CY1111950T1 (en) 32 HUMAN EXTRACTED PROTEINS
WO2001032910A3 (en) 27 human secreted proteins
WO2001036432A3 (en) 18 human secreted proteins
PT868519E (en) DIAGNOSIS AND TREATMENT OF DISORDERS RELATED TO AUR-1 AND / OR AUR-2
WO1998045712A3 (en) 20 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2001012776A3 (en) 18 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000052136A3 (en) Human glycosylation enzymes
WO2000063230A3 (en) 49 human secreted proteins
WO2001062891A3 (en) 207 human secreted proteins
EP1042342A4 (en) 53 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2001012775A3 (en) 25 human secreted proteins
WO2001023409A8 (en) 38 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO2003052377A9 (en) 41 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2002099066A3 (en) 20 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2001 526559

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2384584

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000968411

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000968411

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000968411

Country of ref document: EP